{"title":"Evaluation of success and toxicity of autologous stem cell transplantation in patients with multiple myeloma in the geriatric age group","authors":"M. Ucar, S. Dagdas, F. Ceran, M. Falay, G. Özet","doi":"10.17352/sscrt.000012","DOIUrl":null,"url":null,"abstract":"Background: Our objective in this study is to compare the outcomes of patients with multiple myeloma \n(MM) over 65 years of age who had autologous hematopoietic stem cell transplantation (AHSCT) with the \noutcomes of patients under 65 years of age.","PeriodicalId":227339,"journal":{"name":"Studies on Stem Cells Research and Therapy","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Studies on Stem Cells Research and Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/sscrt.000012","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Our objective in this study is to compare the outcomes of patients with multiple myeloma
(MM) over 65 years of age who had autologous hematopoietic stem cell transplantation (AHSCT) with the
outcomes of patients under 65 years of age.